Suppr超能文献

左心室重构可预测植入式心律转复除颤器二级预防患者室性快速性心律失常的复发。

Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention.

作者信息

Lee Wei-Chieh, Chen Huang-Chung, Chen Yung-Lung, Tsai Tzu-Hsien, Pan Kuo-Li, Lin Yu-Sheng, Chen Mien-Cheng

机构信息

Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta Pei Road, Niao Sung District, Kaohsiung City, 83301, Taiwan.

Division of Cardiology, Chang Gung Memorial Hospital, Chiayi, Taiwan.

出版信息

BMC Cardiovasc Disord. 2016 Nov 21;16(1):231. doi: 10.1186/s12872-016-0416-y.

Abstract

BACKGROUND

Implantable cardioverter defibrillator (ICD) is an effective treatment for secondary prevention of ventricular tachycardia/ventricular fibrillation (VT/VF). Left ventricular (LV) remodeling may develop before ICD implant and over time. However, it remains unclear how LV remodeling affects subsequent risk for recurrence VT/VF in ICD recipients under optimal medical therapy.

METHODS

From May of 2004 to June of 2015, 144 patients received ICD implantation for secondary prevention were enrolled in this study. All information interrogated from ICD devices during follow-up or ICD therapy history (anti-tachycardia pacing and shock therapy) were reviewed and validated the occurrences of VT/VF.

RESULTS

At a mean follow-up of 1110.5 ± 860.6 days, 53 patients (36.8%) had recurrence of VT/VF episodes and 91 patients had no recurrence of VT/VF episode after ICD implant. Left ventricular end-diastolic volume (LVEDV) > 163.5 mL had significant predictive value for VT/VF recurrence (area under the curve: 0.602, p = 0.041). Moreover, the percentage of patients with LVEDV >163.5 mL was significantly higher in patients with recurrent VT/VF than patients without recurrent VT/VF (62.3 vs 40.0%, p = 0.010). Left ventricular ejection fraction ≤ 30% (p = 0.031), LVEDV > 163.5 mL (p = 0.012) and QRS width > 125 msec (p = 0.049) were significant predictors for VT/VF recurrence by univariate Cox regression analysis. However, only LVEDV > 163.5 mL (hazard ratio: 2.549, 95% confidence interval: 1.249 ~ 5.201, p = 0.010) and QRS width > 125 msec (hazard ratio: 2.173, 95% confidence interval: 1.030 ~ 4.586, p = 0.042) were independent predictors for recurrence of VT/VF after multivariable adjustment.

CONCLUSION

LV remodeling and QRS width > 125 msec were independent predictors for VT/VF recurrence in secondary prevention ICD recipients under optimal medical therapy, independent of LV ejection fraction.

摘要

背景

植入式心脏复律除颤器(ICD)是室性心动过速/心室颤动(VT/VF)二级预防的有效治疗方法。左心室(LV)重塑可能在ICD植入前及随时间发展。然而,在最佳药物治疗下,LV重塑如何影响ICD植入患者后续VT/VF复发风险仍不清楚。

方法

2004年5月至2015年6月,144例接受ICD植入进行二级预防的患者纳入本研究。回顾随访期间从ICD设备查询到的所有信息或ICD治疗史(抗心动过速起搏和电击治疗),并验证VT/VF的发生情况。

结果

平均随访1110.5±860.6天,53例患者(36.8%)ICD植入后有VT/VF发作复发,91例患者无VT/VF发作复发。左心室舒张末期容积(LVEDV)>163.5 mL对VT/VF复发有显著预测价值(曲线下面积:0.602,p = 0.041)。此外,VT/VF复发患者中LVEDV>163.5 mL的患者百分比显著高于无VT/VF复发患者(62.3%对40.0%,p = 0.010)。单因素Cox回归分析显示,左心室射血分数≤30%(p = 0.031)、LVEDV>163.5 mL(p = 0.012)和QRS宽度>125毫秒(p = 0.049)是VT/VF复发的显著预测因素。然而,多变量调整后,只有LVEDV>163.5 mL(风险比:2.549,95%置信区间:1.2495.201,p = 0.010)和QRS宽度>125毫秒(风险比:2.173,95%置信区间:1.0304.586,p = 0.042)是VT/VF复发的独立预测因素。

结论

在最佳药物治疗下,LV重塑和QRS宽度>12毫秒是二级预防ICD植入患者VT/VF复发的独立预测因素,与左心室射血分数无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f10/5117501/acfdcac033bc/12872_2016_416_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验